Plain-English translation of NCT07270003 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a new medication called can help treat palmoplantar pustulosis (PPP)—a long-term skin condition that causes painful, itchy blisters, redness, and scaling on the hands and feet. Researchers want to see if this medication reduces these symptoms safely and effectively, especially for people who haven't had good results with other treatments.
Current treatments for PPP—like creams, older pills, and expensive injectable drugs—often don't work well, cause uncomfortable side effects, or stop working quickly. This trial exists because patients with PPP need better options.
You likely qualify if…
You likely don't qualify if…
You would take one 4-milligram tablet of the medication by mouth once daily for 12 weeks. During this time, you cannot use other PPP treatments (such as creams, light therapy, or other systemic drugs), though basic moisturizers and medications for other health conditions are allowed. You will have appointments before the study starts and regular follow-up visits to check how well the medication is working, whether your symptoms improve, and whether you have any side effects.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China